Le Lézard
Classified in: Environment, Health
Subjects: ENP, ANW, CFG

Health Canada to consult on plan to phase out most uses of the neonicotinoids clothianidin and thiamethoxam


Clothianidin and thiamethoxam are being measured at levels that are harmful to aquatic insects, a key source of food for fish, birds and other animals

OTTAWA, Aug. 15, 2018 /CNW/ - Protecting the health and safety of Canadians and their environment is a priority for the Government of Canada. That is why Health Canada regularly reviews all pesticides to make sure they continue to meet modern health and safety standards.

Following special reviews for two neonicotinoid pesticides, clothianidin and thiamethoxam, Health Canada's Pest Management Regulatory Agency has found that these substances are being measured at levels that are harmful to aquatic insects. These aquatic insects, which are a source of food for fish, birds and other animals, are an important part of the ecosystem. Based on these findings, Health Canada is proposing to phase out all outdoor agricultural and turf uses for clothianidin, and all outdoor agricultural and ornamental uses for thiamethoxam in the next three to five years.

Health Canada has published proposed special review decisions for both pesticides. These proposals will be subject to a 90-day consultation period, during which stakeholders and interested parties can submit comments on the proposed decision and provide additional data for consideration. Final special review decisions are expected to be announced at the end of 2019 and will take into consideration any comments or new information received during the consultation period.

Over the last decade, the amount of neonicotinoids used in agriculture has increased substantially. Recent water monitoring data indicate that neonicotinoids being detected in some Canadian water bodies are at levels that cause harm to aquatic insect populations.

Quick Facts

Related Products

Backgrounder: Neonicotinoid Pesticides and the Proposed Special Review Decisions for Clothianidin and Thiamethoxam  
Special Review of Clothianidin Risk to Aquatic Invertebrates: Proposed Decision for Consultation  
Special Review of Thiamethoxam Risk to Aquatic Invertebrates: Proposed Decision for Consultation

 

SOURCE Health Canada


These press releases may also interest you

at 07:45
Redwood Scientific Technologies Inc. ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities. The New York-based firm will only focus on enhancing and expanding its nicotine...

at 07:35
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...

at 07:35
Accuray Incorporated announced today that as part of its commitment to advancing patient care the company has opened a new training center in...

at 07:30
The "Drug Delivery Companies Compendium 2024" directory has been added to ResearchAndMarkets.com's offering. The Drug Delivery Companies Compendium is a cost-effective, time-saving product that answers all of your questions about Drug Delivery...

at 07:30
Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it has scheduled its...

at 07:30
Biomed Israel, the premier international Life Science and HealthTech conference in Israel, will take place on May 21-23, 2024, at the David InterContinental Hotel in Tel Aviv, Israel. The event presents a unique opportunity for global healthcare and...



News published on and distributed by: